Antiseizure Medicine Blood Levels — When Monitoring Helps

A blood test can sometimes measure the concentration of an antiseizure medicine.

The number can be useful, but it is not a universal seizure-control score.

Therapeutic drug monitoring is most useful when it answers a specific clinical question.

No single perfect level

Laboratories may report reference ranges, but people differ. One person may be seizure-free below that range while another may require a higher concentration and tolerate it well. Clinical response remains central.

An individual baseline can be powerful

If someone is stable and doing well, a level measured at that time can sometimes become a personal reference. Later, clinicians can compare it with a new result if seizures, side effects, pregnancy or drug interactions change the picture.

When levels can help

Monitoring may help when clinicians are investigating:

• possible toxicity

• unexpected breakthrough seizures

• suspected missed doses

• drug interactions

• major kidney or liver changes

• pregnancy-related changes

• unexplained loss of seizure control

Sample timing matters

A sample just after a dose can differ from one collected before the next dose. Clinicians need to know when the last dose was taken, the formulation and when blood was drawn.

Total versus free concentration

Some medicines bind strongly to blood proteins. Pregnancy, illness or low albumin can change protein binding, so total concentration may not perfectly represent the active unbound fraction in unusual situations.

A low result is not automatically a dose increase

A low concentration may reflect sample timing, missed doses, an interaction, altered absorption or a genuine need for adjustment. The result has to be interpreted alongside seizures and side effects.

A high result is not automatically toxicity

Some people tolerate concentrations above a laboratory reference range, while another person may experience adverse effects within it. The patient is more important than the printed range.

Why routine testing is not always needed

For a clinically stable person with no relevant change, repeated levels may add little. Monitoring is most useful when there is a reason to believe the information could change management.

Sources and further reading

NICE NG217 — Principles of treatment, safety, monitoring and withdrawal
UK evidence-based guidance on monitoring, adverse effects, shared decision making and planned withdrawal.

World Health Organization — Antiseizure medicines for management of epilepsy in adults and children
International recommendations on antiseizure-medicine choices and important safety considerations.

ILAE — Epilepsy Surgery
International surgical and neurostimulation resources, including evidence reviews and referral guidance.

Information reviewed: September 2026.

This page provides general educational information. The usefulness of blood-level monitoring depends on the specific medicine and clinical situation.